Top NIH researcher says Zika vaccine should be available within 2 years

  • Small
  • Medium
  • Large

Mark Challberg, PhD, program officer for flaviviruses at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, said a vaccine for the Zika virus should be available in one to two years, according to The Kansas City Star.

Dr. Challberg made the comments Monday while speaking at a Kansas City Life Sciences Institute symposium entitled "Preventing the Next Pandemic." During the symposium, he described the federal response to Zika as a redemptive effort in the wake of the 2014 West Africa Ebola outbreak.

"I think the U.S. government was somewhat embarrassed by our response to the Ebola outbreak," said Dr. Challberg, according to The Kansas City Star. "There was a real lack of coordination in what was happening between the various U.S. government agencies during that time, at least at the outset. So when the Zika virus came on board, there was a concerted effort to try to have a coordinated U.S. government response."

To read the full report from The Kansas City Star, click here.

More articles on infection control: 
2 cases of Campylobacter infection identified in Washington 
8 things to know about new hyper-resistant, hypervirulent K. pneumoniae strain 
2 NYC residents infected with Legionnaires' in same apartment building

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars